The main purpose of the trial is to advance our knowledge on the possible mechanism
underlying the catabolic effects of long-term treatment with glucocorticoid.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Collaborator:
The Ministry of Science, Technology and Innovation, Denmark